HuGE Literature Finder
Records
1
-
30
| Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort. BJUI compass 2023 2 4 (2): 156-163. Mian Abrar, Wei Jun, Shi Zhuqing, Rifkin Andrew S, Zheng S Lilly, Glaser Alexander P, Kearns James T, Helfand Brian T, Xu Jianfe |
| Association of polymorphisms in TGFB1, XRCC1, XRCC3 genes and CD8 T-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer. Scientific reports 2022 Dec 12 (1): 21306. Mališi? Emina, Petrovi? Nina, Brengues Muriel, Azria David, Mati? Ivana Z, Srbljak ?uk Ivana, Kop?ali? Katarina, Stanojkovi? Tatjana, Nikitovi? Mari |
| Prioritization and Meta-analysis of regulatory SNPs identified IL6, TGFB1, TLR9 and MMP7 as significantly associated with cervical cancer. Cytokine 2022 Jul 157 155954. Das Agneesh Pratim, Chopra Meenu, Agarwal Subhash |
| Identification of Metabolism-Related Gene-Based Subgroup in Prostate Cancer. Frontiers in oncology 2022 12 909066. Yu Guopeng, Liang Bo, Yin Keneng, Zhan Ming, Gu Xin, Wang Jiangyi, Song Shangqing, Liu Yushan, Yang Qing, Ji Tianhai, Xu B |
| SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer. Annals of clinical and laboratory science 2022 12 52 (6): 904-917. Huang Yufan, You Maojin, Wu Qingfeng, Zhu Wei, Guo Fei, Lin Wangch |
| Systematic Analysis of the Expression and Prognosis of Fc? Receptors in Clear Cell Renal Cell Carcinoma. Frontiers in oncology 2022 4 12 755936. Nie Wenyuan, Yao Yong, Luo Benjun, Zhu Jiyin, Li Shaocheng, Yang Xiaoteng, Luo Tao, Liu Wei, Yan Shibi |
| Association of TGFB1 gene polymorphisms with cervical cancer in Bangladeshi women: A case-control study. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2021 5 43 (1): 27-35. Apu Mohd Nazmul Hasan, Aktar Most Nasrin, Rahman Md Morshadur, Mostaid Md Sha |
| CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis. Frontiers in molecular biosciences 2021 5 8 674863. Guo Lihao, Li Boxin, Lu Zhaohong, Liang Hairong, Yang Hui, Chen Yuting, Zhu Shiheng, Zeng Minjuan, Wei Yixian, Liu Tonggong, Jiang Tikeng, Xuan Mei, Tang Huanw |
| Clinical utility of TGFB1 and its receptors (TGFBR1 and TGFBR2) in thyroid nodules: evaluation based on single nucleotide polymorphisms and mRNA analysis. Archives of endocrinology and metabolism 2021 4 65 (2): 172-184. Peres Karina Colombera, Teodoro Larissa, Amaral Laís Helena Pereira, Teixeira Elisângela Souza, Barreto Icléia Siqueira, de Freitas Leandro Luiz Lopes, Maximo Valdemar, Assumpção Lígia V Montalli, Bufalo Natassia Elena, Ward Laura Steri |
| Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer. Frontiers in oncology 2021 11 697955. Shiota Masaki, Fujimoto Naohiro, Matsumoto Takashi, Tsukahara Shigehiro, Nagakawa Shohei, Ueda Shohei, Ushijima Miho, Kashiwagi Eiji, Takeuchi Ario, Inokuchi Junichi, Uchiumi Takeshi, Eto Masatos |
| DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer. Frontiers in oncology 2021 10 11 708294. Dai Jiawei, Jiang Minlin, He Kan, Wang Hao, Chen Peixin, Guo Haoyue, Zhao Wencheng, Lu Hui, He Yayi, Zhou Caic |
| Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma. Frontiers in cellular neuroscience 2021 8 15 704344. Lv Lei, Zhang Yuliu, Zhao Yujia, Wei Qinqin, Zhao Ye, Yi Qi |
| FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer. Frontiers in immunology 2021 11 12 758648. Zhong Anyuan, Chen Ting, Xing Yufei, Pan Xue, Shi Minh |
| Identification of Risk Loci for Radiotoxicity in Prostate Cancer by Comprehensive Genotyping of TGFB1 and TGFBR1. Cancers 2021 11 13 (21): . Guhlich Manuel, Hubert Laura, Mergler Caroline Patricia Nadine, Rave-Fraenk Margret, Dröge Leif Hendrik, Leu Martin, Schmidberger Heinz, Rieken Stefan, Hille Andrea, Schirmer Markus Ant |
| Somatic mutations in benign breast disease tissues and association with breast cancer risk. BMC medical genomics 2021 7 14 (1): 185. Winham Stacey J, Wang Chen, Heinzen Ethan P, Bhagwate Aditya, Liu Yuanhang, McDonough Samantha J, Stallings-Mann Melody L, Frost Marlene H, Vierkant Robert A, Denison Lori A, Carter Jodi M, Sherman Mark E, Radisky Derek C, Degnim Amy C, Cunningham Julie |
| TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs. Frontiers in molecular biosciences 2021 7 8 690500. Wang Kai, Feng Xingjun, Zheng Lingzhi, Chai Zeying, Yu Junhui, You Xinxin, Li Xiaodan, Cheng Xiaodo |
| Effect of functional variant rs11466313 on breast cancer susceptibility and TGFB1 promoter activity. Breast cancer research and treatment 2020 Aug . Zhou Yan-Ting, Zheng Li-Yuan, Wang Ya-Jun, Yang Li, Xie Yun-Tao, Panda Ipsita, Tian Xin-Xia, Fang Wei-Ga |
| Association Between Polymorphisms in DNA Damage Repair Genes and Radiation Therapy-Induced Early Adverse Skin Reactions in a Breast Cancer Population: A Polygenic Risk Score Approach. International journal of radiation oncology, biology, physics 2020 Jan . Lee Eunkyung, Eum Sung Y, Slifer Susan H, Martin Eden R, Takita Cristiane, Wright Jean L, Hines Robert B, Hu Jennifer |
| Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population. Scientific reports 2020 Jan 10 (1): 144. Corredor Zuray, Filho Miguel Inácio da Silva, Rodríguez-Ribera Lara, Velázquez Antonia, Hernández Alba, Catalano Calogerina, Hemminki Kari, Coll Elisabeth, Silva Irene, Diaz Juan Manuel, Ballarin José, Vallés Prats Martí, Calabia Martínez Jordi, Försti Asta, Marcos Ricard, Pastor Susa |
| The Influence of Family History on Stage and Survival of Gastric Cancer According to the <i>TGFB1</i> C-509T Polymorphism in Korea. Gut and liver 2020 Jan . Kim Hee Jin, Kwon Mingu, Kim Nayoung, Lee Jae Bong, Won Sung |
| An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma. Frontiers in oncology 2020 6 10 853. Mo Zhuomao, Wang Yongdan, Cao Zhirui, Li Pan, Zhang Shij |
| Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma. Cancer cell international 2020 6 20 210. Lv Lei, Zhao Yujia, Wei Qinqin, Zhao Ye, Yi Qi |
| Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer. Journal of genetics 2020 99 . Özgöz Asuman, Içduygu FadIme Mutlu, Yükseltürk Aysegül, SamlI Hale, Öztürk Kuyas HekImler, Baskan Zuh |
| Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review. Pharmacogenomics and personalized medicine 2020 6 13 167-180. Jamshidi Mohammad, Mohammadi Pour Somayeh, Mahmoudian-Sani Mohammad-Re |
| Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination. Gut 2020 11 70 (10): 1823-1832. Sundar Raghav, Liu Drolaiz Hw, Hutchins Gordon Ga, Slaney Hayley L, Silva Arnaldo Ns, Oosting Jan, Hayden Jeremy D, Hewitt Lindsay C, Ng Cedric Cy, Mangalvedhekar Amrita, Ng Sarah B, Tan Iain Bh, Tan Patrick, Grabsch Heike |
| Transforming growth factor beta 1 (TGF?1) plasmatic levels in breast cancer and neoplasia-free women: Association with patients' characteristics and TGFB1 haplotypes. Cytokine 2020 4 130 155079. Vitiello Glauco Akelinghton Freire, Amarante Marla Karine, Oda Julie Massayo Maeda, Hirata Bruna Karina Banin, de Oliveira Carlos Eduardo Coral, Campos Clodoaldo Zago, de Oliveira Karen Brajão, Guembarovski Roberta Losi, Watanabe Maria Angelica Eha |
| HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes. Oral oncology 2019 Dec 100 104488. Chatfield-Reed Kate, Gui Shanying, O'Neill Wendi Q, Teknos Theodoros N, Pan Quint |
| Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2019 Aug 41 (8): 1010428319869096. Hadj-Ahmed Mariem, Ghali Rabeb M, Bouaziz Hanen, Habel Azza, Stayoussef Mouna, Ayedi Mouna, Hachiche Monia, Rahal Khaled, Yacoubi-Loueslati Besma, Almawi Wassim |
| Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes. Breast cancer research and treatment 2019 Jul . Vitiello Glauco Akelinghton Freire, Amarante Marla Karine, Banin-Hirata Bruna Karina, Campos Clodoaldo Zago, de Oliveira Karen Brajão, Losi-Guembarovski Roberta, Watanabe Maria Angelica Eha |
| Inherited alterations of TGF beta signaling components in Appalachian cervical cancers. Cancer causes & control : CCC 2019 8 30 (10): 1087-1100. Knobloch Thomas J, Peng Juan, Hade Erinn M, Cohn David E, Ruffin Mack T, Schiano Michael A, Calhoun Byron C, McBee William C, Lesnock Jamie L, Gallion Holly H, Pollock Jondavid, Lu Bo, Oghumu Steve, Zhang Zhaoxia, Sears Marta T, Ogbemudia Blessing E, Perrault Joseph T, Weghorst Logan C, Strawser Erin, DeGraffinreid Cecilia R, Paskett Electra D, Weghorst Christopher |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: